Market cap
$646.1m
End-of-day close multiplied by current shares on issue.
SAN · NZX
Sanford is an NZX-listed primary industries / seafood company. Its latest covered result is FY26, with FY25 - FY26 of source-backed result history on Annolyse.
Latest result
FY26, released 17 November 2026
| Metric | Value | Change |
|---|---|---|
| Revenue | $598.6m | ↑ +2.5% |
| Operating profit | $112.3m | ↑ +10.1% |
| NPAT | $74.5m | ↑ +17.0% |
| Operating cash flow | $89.6m | ↓ -33.8% |
| OCF / Operating profit % | 79.8% | ↓ -52.9pp |
| Net debt | $53.6m | ↓ -42.6% |
| Net debt / Operating profit | 0.48x | ↓ -47.8% |
| ROE % | 9.2% | ↑ +0.6pp |
| DPS | 5.0c | — Flat |
| Payout ratio vs NPAT % | 12.5% | ↓ -2.2pp |
Source: latest published briefing (FY26, released 17 November 2026). Change compares against the prior equivalent period: FY25, released 18 November 2025.
Valuation
Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.
The latest close and share count context for the market price.
Market cap
$646.1m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
8.67x
Recent market cap compared with trailing earnings.
EPS
0.80
Recent filing-derived earnings per share.
PEG
0.51x
P/E compared with recent earnings growth.
EV/EBITDA
6.23x
Enterprise value compared with recent EBITDA.
P/FCF
10.2x
Market cap compared with recent free cash flow.
P/B
0.8x
Market value compared with latest reported equity.
Yield and investment-company valuation where supported.
Dividend yield
1.4%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.
Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.
Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.
Chat
Ask follow-up questions about Sanford's latest result and company history.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Financial history
The latest period is shown first.
| Metric | FY2612 MONTHS17 November 2026 | HY266 MONTHS14 May 2026 | FY2512 MONTHS18 November 2025 | Trend |
|---|---|---|---|---|
| Revenue | $598.6m | $270.2m | $584.1m | Chart |
| Revenue growth % | 2.5% | -5.5% | 0.2% | Chart |
| Operating profit | $112.3m | $64m | $102m | Chart |
| Operating profit margin % | 18.8% | 23.7% | 17.5% | Chart |
| PBT | $104.4m | $59.8m | $90m | Chart |
| PBT growth % | 16.1% | 25.6% | 140.6% | Chart |
| NPAT | $74.5m | $42.4m | $63.7m | Chart |
| NPAT growth % | 17.0% | 24.7% | 223.4% | Chart |
| Operating cash flow | $89.6m | $13.7m | $135.3m | Chart |
| OCF / Operating profit % | 79.8% | 21.4% | 132.7% | Chart |
| FCF pre-lease | $63.3m | $7m | $112.3m | Chart |
| DPS | 5.0c | 5.0c | 5.0c | Chart |
| Payout ratio vs NPAT % | 12.5% | 11.0% | 14.7% | Chart |
| Annual payout ratio vs EPS % | 12.5% | — | 14.7% | Chart |
| ROE % | 9.2% | 5.4% | 8.6% | Chart |
| Net debt | $53.6m | $102.1m | $93.4m | Chart |
| Net debt / Operating profit | 0.48x | 1.6x | 0.92x | Chart |
| Debtor days | 49 | 55 | 39 | Chart |
| Inventory days | 53 | 76 | 58 | Chart |
| Total assets | $1.1b | $1.1b | $1b | Chart |
Reference: annolyse.ai/companies/san
Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.
These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.
Reported revenue across covered periods.
Like-period revenue growth where comparable.
Company-specific earnings measure where disclosed.
EBITDA-equivalent margin where revenue and earnings are source-backed.
Statutory profit after tax.
Cash generated from operations.
Additional filing-backed metrics for this company. Each point links to the relevant published briefing.
Cash conversion against earnings.
Operating cash flow less capex before leases.
Return on equity.
Borrowings less cash; negative values indicate net cash.
Leverage ratio, suppressed where earnings are not meaningful.
Dividend per share declared for the period.
Dividend payout against statutory NPAT.
Receivables days where the working-capital inputs are source-backed.
Inventory days where the working-capital inputs are source-backed.
Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.
The setup & the reality
The latest result is checked against what the prior briefing said to watch.
Historical setup
Previous analysisHY26Result releasedAnnolyse analysis published
From Record NPAT up 24.7% but operating cash collapsed 72.4%
No forward targets or guidance were disclosed. Historical shape shows revenue is roughly evenly split (HY25 took 49% of FY25 revenue) while NPAT has been H1-weighted (HY25 took 53.4% of FY25 NPAT). Annualising current revenue gives $540.3m, tracking below FY25's $584.1m, so revenue is the soft variable. On NPAT, H1 of $42.4m has already exceeded the implied H2 NPAT contribution of $29.7m from last year, so even a modest H2 result would deliver a record full year — but the cash question, not the P&L question, is what governs the FY read.
Open questions
This briefing cannot assess pricing, volume, and biological-asset assumptions inside each segment, nor management's intent on capex phasing and inventory normalisation in H2.
Primary issuer documents used for the FY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.
FY26 Annual Report
FY26 / financial reportFY26 Media Release
FY26 / media releaseFY26 Results Announcement
FY26 / results announcementFY26 Results Presentation
FY26 / results presentationFY25 Annual Report
FY25 / financial reportFY25 Media Release
FY25 / media releaseFY25 Results Announcement
FY25 / results announcementFY25 Results Presentation
FY25 / results presentationHY26 Interim Report
HY26 / financial reportHY26 Media Release
HY26 / media releaseHY26 Results Announcement
HY26 / results announcementHY26 Results Presentation
HY26 / results presentationAnnual Meeting 2025 Results
HY26 / commentaryPeer context
These companies share a broad sector but may not be direct peers. Compare them only where the underlying measures are genuinely comparable.
Archive
The full chronological archive contains every published result briefing.
FY26 · Released 17 November 2026
Weaker cash generation and sharply uneven segment results temper earnings growth, although net debt declined.
HY26 · Released 14 May 2026
A $28.5m inventory build and a $9.1m capex cut delivered the deleveraging story while draining nearly all of the earnings improvement from cash.
FY25 · Released 18 November 2025
Operating recovery is real but NPAT growth of 223.4% is amplified by an effective tax rate that fell from 47.4% to 29.2%.
Get the next Sanford result briefing and five-year history updates by email.